Study Partners

The ONTARGET^® Trial Programme is overseen by a Scientific Steering Committee to ensure that it remains a scientifically sound, well-executed trial, with accurate reporting of the study results.

An Adjudication and Assessment Committee (AAC) will confirm the primary outcome. These are the "adjudicated events". An independent Data and Safety Monitoring Board (DSMB) will oversee patient safety and evaluate the outcome and safety data.

The Scientific Steering Committee Chair and Co-Chair are:

Professor Salim Yusuf, MD, D.Phil, FRCPC, FACC

ONTARGET^® Principal Investigator and Study Chairman

Professor and Director, Division of Cardiology, Department of Medicine, McMaster University Medical Centre, Hamilton General Hospital, Hamilton, Ontario, Canada.

Professor Peter Sleight, MD, FRCPC, FACC

ONTARGET^® Study Co-Chair

Professor Emeritus of Cardiovascular Medicine, University of Oxford, Honorary Consultant Physician, John Radcliff Hospital Oxford, United Kingdom